Status:

NOT_YET_RECRUITING

Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression: the Prospective VASCUL-AID Study

Lead Sponsor:

Amsterdam UMC

Collaborating Sponsors:

Amsterdam UMC, location VUmc

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Conditions:

Abdominal Aorta Aneurism

Peripheral Arterial Disease

Eligibility:

All Genders

40-90 years

Brief Summary

Introduction: Peripheral arterial disease (PAD) and abdominal aortic aneurysm (AAA) are vascular conditions associated with significant morbidity and mortality, with 25% of AAA patients and 23% of PA...

Eligibility Criteria

Inclusion

  • Inclusion Criteria AAA:
  • Males/females between 40 and 90 years of age.
  • Males and females with AAA at inclusion, any diameter \>3 cm (or 1.5x larger than their non-dilated part of the aorta).
  • Include: infrarenal, juxtarenal, pararenal, suprarenal abdominal aortic aneurysms.
  • Exclusion Criteria AAA:
  • Patients with:
  • Insufficient schooling or sensorial deficits that interfere understanding informed consent.
  • Not able to use the VASCUL-AID mobile health app (that will be provided in Dutch, English, German, Portuguese, Serbian, Finish, Swedish languages).
  • Proven or highly suspected for infected, mycotic AAA
  • Previous AAA surgery or planned for an AAA surgery within 6 months
  • Ruptured AAA
  • Inclusion Criteria PAD:
  • Males/females between 40 and 90 years of age.
  • Patients with peripheral arterial disease stage Fontaine 2a and 2b at inclusion. Medical history (e.g. CLTI) does not matter, current disease stage is leading at inclusion.
  • Exclusion Criteria PAD:
  • Patients with:
  • Insufficient schooling or sensorial deficits that interfere understanding informed consent.
  • Not able to use the VASCUL-AID mobile health app (provided in Dutch, English, German, Portuguese, Serbian, Finnish, Swedish languages).

Exclusion

    Key Trial Info

    Start Date :

    September 1 2025

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2030

    Estimated Enrollment :

    1100 Patients enrolled

    Trial Details

    Trial ID

    NCT07187700

    Start Date

    September 1 2025

    End Date

    December 1 2030

    Last Update

    September 23 2025

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

    Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression: the Prospective VASCUL-AID Study | DecenTrialz